Searched over 200M research papers
8 papers analyzed
These studies suggest that fatty heart symptoms can include general debility, shortness of breath on exertion, and arrhythmias.
20 papers analyzed
Fatty heart disease, also known as fatty degeneration of the heart, is a condition characterized by the abnormal accumulation of fat in the heart muscle. This condition has been historically recognized but has seen fluctuating attention in medical literature over the years . The condition is particularly concerning due to its association with sudden death and angina pectoris.
The primary symptoms of fatty heart disease include general debility, feebleness, and a sense of languor and somnolence. Patients often experience shortness of breath upon exertion, and their pulse is typically small, collapsing, and feeble, with blood pressure below normal. These symptoms are indicative of the heart's reduced ability to pump blood effectively, leading to overall physical weakness and fatigue.
Obesity is a significant risk factor for fatty heart disease. Studies have shown that the condition is prevalent among obese individuals, with a strong correlation between body mass index (BMI) and the amount of fat in the heart muscle. This fat accumulation can impair diastolic filling, even in asymptomatic obese individuals, highlighting the importance of early detection and intervention.
Fatty heart disease is often accompanied by systemic inflammation and cardiac damage. The excessive accumulation of fatty acids and triglycerides in the heart can lead to impaired calcium signaling, mitochondrial dysfunction, and increased production of reactive oxygen species. These changes result in myocardial inflammation and dysfunction, contributing to left ventricular hypertrophy and overall heart disease. The enlargement of epicardial fat is also associated with the release of pro-inflammatory and pro-atherogenic cytokines, further exacerbating cardiac issues.
In some cases, fatty heart disease can present with arrhythmias and conduction defects. These symptoms are particularly noted in patients with inherited disorders of fatty acid oxidation. Arrhythmias such as ventricular tachycardia, atrial tachycardia, and various conduction blocks have been observed, especially in newborns and infants with these metabolic disorders. The accumulation of arrhythmogenic intermediary metabolites of fatty acids is believed to be responsible for these conduction abnormalities.
Preventing and managing fatty heart disease involves lifestyle modifications and pharmacologic interventions aimed at reducing caloric intake and increasing fatty acid oxidation. These measures are crucial in mitigating the progression of the disease and improving cardiac function. Additionally, the use of n-3 polyunsaturated fatty acids (PUFAs) has shown promise in improving left ventricular function and reducing hospitalizations for heart failure in patients with nonischemic dilated cardiomyopathy.
Fatty heart disease is a complex condition with a range of symptoms primarily related to general debility, shortness of breath, and arrhythmias. Obesity and systemic inflammation play significant roles in its development and progression. Early detection and intervention through lifestyle changes and pharmacologic treatments are essential in managing the disease and improving patient outcomes. Understanding the symptoms and underlying mechanisms of fatty heart disease is crucial for effective diagnosis and treatment.
Most relevant research papers on this topic